This study is looking at two common treatments for dyspepsia (upset stomach or indigestion), GERD (acid reflux), and acid reflux in people who come to the emergency department. Researchers want to see if intravenous (IV) famotidine or oral Maalox/Mylanta is better at reducing pain. You might be able to join if you are at least 18 years old, have been diagnosed with dyspepsia, and have upper abdominal pain that is at least a 3 on a pain scale. The study aims to see which treatment reduces pain more effectively within one hour. The current recruitment status is unclear.

Study design

This is an interventional study planning to enroll about 80 participants. You would be randomly assigned to receive either intravenous famotidine or oral Maalox/Mylanta.

What's involved

You would receive one of the study medications and have your pain measured at several time points over 60 minutes.

Compensation

Not stated in the trial record.

Follow-up

Your pain will be measured for 60 minutes after receiving the study medication.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.